Cortesi, Paolo Angelo, et al. “The Value and Sustainability of Ocrelizumab in Relapsing Multiple Sclerosis: A Cost-Effectiveness and Budget Impact Analysis”. Farmeconomia. Health Economics and Therapeutic Pathways, vol. 20, no. 1, July 2019, doi:10.7175/fe.v20i1.1435.